Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases: Does the primary disease site matter?

  • Neda Amini
  • , Nikolaos Andreatos
  • , Georgios Antonios Margonis
  • , Stefan Buettner
  • , Jaeyun Wang
  • , Boris Galjart
  • , Doris Wagner
  • , Kazunari Sasaki
  • , Anastasios Angelou
  • , Jinger Sun
  • , Carsten Kamphues
  • , Andrea Beer
  • , Daisuke Morioka
  • , Inger Marie Løes
  • , Efstathios Antoniou
  • , Katsunori Imai
  • , Emmanouil Pikoulis
  • , Jin He
  • , Klaus Kaczirek
  • , George Poultsides
    • Cornelis Verhoef, Per Eystein Lønning, Itaru Endo, Hideo Baba, Peter Kornprat, Federico NAucejo, Martin E. Kreis, Wolfgang L. Christopher, Matthew J. Weiss, Bashar Safar, Richard Andrew Burkhart

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases: Does the primary disease site matter?'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology